Frontiers in Cellular and Infection Microbiology | Antibiotic Resistance and New Antimicrobial drugs

Original Research

Published on 27 Nov 2023

Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2

in Antibiotic Resistance and New Antimicrobial drugs

Shaibu Oricha Bello
Mustapha Umar Imam
Muhammad Bashir Bello
Abdulmajeed Yunusa
Adamu Ahmed Adamu
Abdulmalik Shuaibu
Ehimario Uche Igumbor
Zaiyad Garba Habib
Mustapha Ayodele Popoola
Chinwe Lucia Ochu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1273982

2,407 views
1 citation

Methods

Published on 23 Nov 2023

Rapid detection of antimicrobial resistance in methicillin-resistant Staphylococcus aureus using MALDI-TOF mass spectrometry

in Antibiotic Resistance and New Antimicrobial drugs

Josiah J. Rensner
Paul Lueth
Bryan H. Bellaire
Orhan Sahin
Young Jin Lee

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1281155

2,975 views
5 citations

Brief Research Report

Published on 22 Nov 2023

Non-pathogenic Neisseria species of the oropharynx as a reservoir of antimicrobial resistance: a cross-sectional study

in Antibiotic Resistance and New Antimicrobial drugs

Valeria Gaspari
Marielle Ezekielle Djusse
Sara Morselli
Luca Rapparini
Claudio Foschi
Simone Ambretti
Tiziana Lazzarotto
Bianca Maria Piraccini
Antonella Marangoni

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1308550

4,554 views
10 citations

Original Research

Published on 14 Nov 2023

Safety and effectiveness of tigecycline combination therapy in renal transplant patients with infection due to carbapenem-resistant gram-negative bacteria

in Antibiotic Resistance and New Antimicrobial drugs

Qin Wang
Guiyi Liao
Quan Xia
Chaoliang Ge
Handong Ding

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1215288

3,167 views
1 citation

Editorial

Published on 09 Nov 2023

Editorial: Multidrug gram-negative bacilli : current situation and future perspective

in Antibiotic Resistance and New Antimicrobial drugs

Luis Esaú López-Jácome
Rafael Franco-Cendejas
Rodolfo García-Contreras
Elvira Garza-González

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1327413

1,072 views

Original Research

Published on 31 Oct 2023

Identification of an antivirulence agent targeting the master regulator of virulence genes in Staphylococcus aureus

in Antibiotic Resistance and New Antimicrobial drugs

Rekha Arya
Truc Kim
Joo Won Youn
Taeok Bae
Kyeong Kyu Kim

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1268044

2,930 views
9 citations

Original Research

Published on 31 Oct 2023

Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022

in Antibiotic Resistance and New Antimicrobial drugs

Dong-Mei Wang
Hong Liu
Yong-Li Zheng
Yuan-Hong Xu
Yi Liao

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1282902

3,651 views
12 citations

Review

Published on 27 Oct 2023

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host

in Antibiotic Resistance and New Antimicrobial drugs

Alyssa Schami
M. Nurul Islam
John T. Belisle
Jordi B. Torrelles

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1274175

5,372 views
8 citations

Case Report

Published on 16 Oct 2023

Rare tuberculosis in recipients of allogeneic hematopoietic stem cell transplantation successfully treated with contezolid–a typical case report and literature review

in Antibiotic Resistance and New Antimicrobial drugs

Junhong Li
Zhaoxian Yu
Yingyi Jiang
Suihua Lao
Dexian Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1258561

2,962 views
4 citations

Original Research

Published on 13 Oct 2023

Occurrence and characterization of plasmids carrying tmexCD1-toprJ1, blaDHA-1, and blaCTX-M-127, in clinical Klebsiella pneumoniae strains

in Antibiotic Resistance and New Antimicrobial drugs

Ying Qu
Wenji Wang
Qinhong Lu
Jihai Qiu
Dongguo Wang
Liman Ma

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1260066

2,532 views
2 citations

Original Research

Published on 11 Oct 2023

Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates

in Antibiotic Resistance and New Antimicrobial drugs

William Rhys-Williams
Helen Marie Galvin
William Guy Love

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1264456

2,879 views
1 citation

Original Research

Published on 11 Oct 2023

Development of a high-throughput platform to measure plasmid transfer frequency

in Antibiotic Resistance and New Antimicrobial drugs

Kepa Arbé-Carton
Ana Rey-Sogo
Nagore Santos-Fernández
Oihane Altube
Carlos Garbisu
Lide Arana
Itziar Alkorta

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1269732

4,362 views

Editorial

Published on 10 Oct 2023

Editorial: Antimicrobial resistance and one health: from culture to genomics

in Antibiotic Resistance and New Antimicrobial drugs

Akebe Luther King Abia
Asfatou Ndama Traore
Natasha Potgieter

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1294241

1,694 views
1 citation

Original Research

Published on 04 Oct 2023

Platelet factor 4 improves survival in a murine model of antibiotic-susceptible and methicillin-resistant Staphylococcus aureus peritonitis

in Antibiotic Resistance and New Antimicrobial drugs

Nataly P. Podolnikova
Valeryi K. Lishko
Robert Roberson
Zhiqian Koh
Dmitry Derkach
David Richardson
Michael Sheller
Tatiana P. Ugarova

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1217103

2,875 views

Mini Review

Published on 02 Oct 2023

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs

in Antibiotic Resistance and New Antimicrobial drugs

Yuzhen Gu
Wenjuan Nie
Hairong Huang
Xia Yu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1243457

6,205 views
9 citations

Case Report

Published on 29 Sep 2023

Case Report: Omadacycline in the treatment of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in an adolescent patient

in Antibiotic Resistance and New Antimicrobial drugs

Limin Xu
Changquan Fang

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2023.1244398

6,376 views
5 citations